Obesity is an expanding global public health problem and a leading cause of metabolic disorders. The hepatokine
Fetuin B participates in regulating
insulin resistance,
glucose metabolism and
liver steatosis. However, the mechanism underlying
Fetuin B activation remains unclear. Our previous population-based study demonstrated a significant association between serum
Fetuin B and body fat mass in an obese population, which indicates its potential in mediating
obesity-related metabolic disorders. In the present study, we further revealed a significant correlation between
Fetuin B and
leptin, the classic
adipokine released by expanding adipose tissue, in this obese population. Consistently, elevated
Fetuin B and
leptin levels were confirmed in diet-induced obese mice. Furthermore, an in vitro study demonstrated that the
leptin signalling pathway directly activated the transcription and expression of
Fetuin B in primary hepatocytes and AML12 cells in a STAT3-dependent manner. STAT3 binds to the response elements on FetuB promoter to directly activate FetuB transcription. Finally, the mediating effect of
Fetuin B in
insulin resistance induced by
leptin was confirmed according to mediation analysis in this obese population. Therefore, our study identifies leptin-STAT3 as an upstream signalling pathway that activates
Fetuin B and provides new insights into the pathogenic mechanisms of
obesity-related metabolic disorders.